ESS
Price
$269.39Alerts
Change
-$4.47 (-1.63%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
17.49B
82 days until earnings call
Intraday BUY SELL Signals
NURE
Price
$31.73Alerts
Change
-$0.50 (-1.55%)
Updated
Nov 19, 03:56 PM (EDT)
Net Assets
32.41M
Intraday BUY SELL Signals
Interact to see
Advertisement

ESS vs NURE

ESS vs NURE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ESS vs. NURE commentary
Nov 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESS is a StrongBuy and NURE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ESS with price predictions
Nov 18, 2026

ESS in upward trend: 10-day moving average broke above 50-day moving average on November 13, 2026

The 10-day moving average for ESS crossed bullishly above the 50-day moving average on November 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on ESS as a result. In 50 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.

The Moving Average Convergence Divergence (MACD) for ESS just turned positive on November 06, 2026. Looking at past instances where ESS's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.

ESS moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESS advanced for three days, in 165 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 50%.

ESS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 114 of 244 cases where ESS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 47%.

Bearish Trend Analysis

The 10-day RSI Indicator for ESS moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 16 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 31 of 69 cases where ESS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. ESS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 77 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.286) is normal, around the industry mean (2.264). P/E Ratio (42.396) is within average values for comparable stocks, (17.966). Projected Growth (PEG Ratio) (7.018) is also within normal values, averaging (6.621). Dividend Yield (0.038) settles around the average of (0.240) among similar stocks. ESS's P/S Ratio (9.066) is slightly higher than the industry average of (5.580).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for NURE with price predictions
Nov 18, 2026

NURE in upward trend: 10-day moving average moved above 50-day moving average on October 22, 2026

The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.

Bearish Trend Analysis

The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

FUNDAMENTALS RATINGS
ESS: Fundamental Ratings
ESS
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ESSNURE
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
50%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
46%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
71%
COMPARISON
Comparison
Nov 20, 2026
Stock price -- (ESS: $273.86)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESS’s FA Score shows that 1 FA rating(s) are green while .

  • ESS’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESS’s TA Score shows that 7 TA indicator(s) are bullish.

  • ESS’s TA Score: 7 bullish, 3 bearish.

Price Growth

ESS (@Media Conglomerates) experienced а -0.05% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Media Conglomerates industry was -2.30%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was -9.32%.

Reported Earning Dates

ESS is expected to report earnings on Feb 09, 2027.

Industries' Descriptions

@Media Conglomerates (-2.30% weekly)

Companies that operate in these three (or more) areas: broadcasting, cable TV, publishing and movies/entertainment. The companies usually have a large share in these markets. Walt Disney Co . is an example.

View a ticker or compare two or three
Interact to see
Advertisement

ESS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESS has been closely correlated with UDR. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if ESS jumps, then UDR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESS
1D Price
Change %
ESS100%
+1.06%
UDR - ESS
84%
Closely correlated
+0.03%
VMRK - ESS
82%
Closely correlated
-0.78%
MAA - ESS
80%
Closely correlated
-0.68%
CPT - ESS
79%
Closely correlated
-0.32%
REG - ESS
74%
Closely correlated
-0.32%
More

NURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURE
1D Price
Change %
NURE100%
+0.03%
UDR - NURE
83%
Closely correlated
+0.03%
MAA - NURE
82%
Closely correlated
-0.68%
CPT - NURE
80%
Closely correlated
-0.32%
ESS - NURE
76%
Closely correlated
+1.06%
VMRK - NURE
75%
Closely correlated
-0.78%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHFAN9.43-0.16
-1.67%
Brighthouse Financial
HOWL1.03-0.02
-1.90%
Werewolf Therapeutics
INTR3.81-0.11
-2.81%
Inter & Co
PRMB22.96-1.29
-5.32%
Primo Brands Corp.
ALLO0.70-0.05
-6.48%
Allogene Therapeutics